Since the discovery of α-synuclein as a key player in PD, a diverse research community has evolved, focusing on the molecular properties of this protein, and its interaction partner synphilin-1, and the cellular dysfunction that underlies α-synuclein-mediated pathology. This evidence concerns the gene SNCAIP and Parkinson disease.